Skip to main content

Table 4 Commonly reported adverse reactions of sirolimus therapy (occurring in more than 10% of patients)

From: Pulsed oral sirolimus in advanced autosomal-dominant polycystic kidney disease (Vienna RAP Study): study protocol for a randomized controlled trial

Abdominal pain

Acne

Anemia

Aphthae

Arthralgia

Constipation

Diarrhea

Headache

Hypercholesterolemia

Hyperglycemia

Hypertension

Hypertriglyceridemia

Hypokalemia

Hypophosphatemia

Impaired wound healing

Increased serum creatinine

Increased serum lactate dehydrogenase

Nausea

Pain

Peripheral edema

Pneumonitis

Pyrexia

Stomatitis

Thrombocytopenia

Urinary tract infection